Imbruvica Ibrutinib 140 mg Capsules
WHAT IS IMBRUVICA 140 MG CAPSULES ?
Imbruvica 140mg is a targeted therapy. It inhibits the function of Bruton's tyrosine kinase (BTK). BTK is a key signaling molecule of the B-cell receptor signaling complex that plays an important role in the survival of malignant B cells. It blocks signals that stimulate malignant B cells to grow and divide uncontrollably. It is not a chemotherapy drug but one of what are termed "targeted therapies."
WHAT ARE THE USES OF IBRUTINIB 140 MG CAPSULES ?
Ibrutinib is used to treat certain types of non-Hodgkin lymphoma, including mantle cell lymphoma (MCL), Waldenstrom's macroglobulinemia, and chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in people with or without 17p deletion. However, it has not been shown that it can improve symptoms or lengthen survival time in people with this type of lymphoma.
IBRUTINIB COMMON SIDE EFFECTS :
pale skin, easy bruising or bleeding; fever, chills, flu symptoms;nausea, diarrhea; tired feeling; rash; or muscle pain, bone pain.
Stop using Imbruvica and call your doctor at once if you have:
- chest pain and severe dizziness, fast or irregular heartbeats, trouble breathing, feeling like you might pass out;
- fever, swollen gums, painful mouth sores, pain when swallowing, skin sores, cold or flu symptoms, cough, trouble breathing;
- severe weakness or dizziness, confusion, problems with speech, prolonged headache;
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects.